{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T05:03:51Z","timestamp":1780031031831,"version":"3.53.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010374","name":"Stichting Blindenhulp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010374","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gelderse Blindenstichting"},{"name":"Louise Rottinghuisfonds"},{"DOI":"10.13039\/501100010318","name":"Landelijke Stichting voor Blinden en Slechtzienden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010302","name":"Algemene Nederlandse Vereniging ter voorkoming van Blindheid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010302","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stichting Beheer Het Schild"},{"name":"Het Oogfonds"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To assess the risk of conversion of non-exudative macular neovascularisations (NEMNV) in relation to disease history in sustained unilateral neovascular age-related macular degeneration (AMD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This exploratory case-only cohort study included six-monthly visits. Fellow-eye NEMNV were identified using fluorescein and indocyanine green angiography. Patients were stratified by time since first-eye exudation:\u2009&lt;\u20095\u00a0years (G1) or\u2009\u2265\u20095\u00a0years (G2). The primary outcome was the cumulative annual conversion rate of NEMNV, expressed as conversion rate ratios (CRR) with 95% confidence intervals (CI). Secondary outcomes were independent grading of foveal involvement, core vessel, central core vessel, round shape, sharp borders, and lesion growth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 134 patients (65.7% female) were included. Mean age at baseline was 74.2\u00a0years (SD 8.0). Median time since first-eye exudation was 2.9\u00a0years (IQR 1.0\u20136.3). Patients in G2 had an earlier age at first-eye exudation (66.0 [9.1] years) than G1 (72.7 [7.8]; P\u2009&lt;\u2009.001). Seven NEMNV lesions were identified (G1:2, G2:5). Cumulative conversion rates were 22.1% overall, 14.3% in G1, and 27.1% in G2. CRR were 2.3 (95% CI 0.6\u20136.2), 1.3 (95% CI 0.0 \u2013 7.8), and 4.0 (95% CI 0.7 \u2013 16.8). All but one NEMNV showed growth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this limited sample, most NEMNV show growth time regardless of conversion to exudative AMD and appear at a higher risk of conversion. The rate of conversion varies with the age of onset of first-eye exudation. Evaluating potential predictive signs of conversion may benefit from incorporating disease history with vascular features.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00417-026-07275-4","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:29:42Z","timestamp":1780028982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical course of non-exudative macular neovascularisations in sustained unilateral neovascular age-related macular degeneration"],"prefix":"10.1007","author":[{"given":"Francesco","family":"Cinque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie C. A. ten","family":"Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahfam","family":"Shahabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"de Breuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas. J.","family":"Heesterbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline C. W.","family":"Klaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel B.","family":"Hoyng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara T. E.","family":"Lechanteur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"7275_CR1","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.ophtha.2017.05.035","volume":"124","author":"JM Colijn","year":"2017","unstructured":"Colijn JM, Buitendijk GHS, Prokofyeva E, Alves D, Cachulo ML, Khawaja AP, Cougnard-Gregoire A, Merle BMJ, Korb C, Erke MG, Bron A, Anastasopoulos E, Meester-Smoor MA, Segato T, Piermarocchi S, de Jong P, Vingerling JR, Topouzis F, Creuzot-Garcher C, Bertelsen G, Pfeiffer N, Fletcher AE, Foster PJ, Silva R, Korobelnik JF, Delcourt C, Klaver CCW (2017) Prevalence of Age-Related Macular Degeneration in Europe: The Past and the Future. Ophthalmology 124:1753\u20131763. https:\/\/doi.org\/10.1016\/j.ophtha.2017.05.035","journal-title":"Ophthalmology"},{"key":"7275_CR2","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/s2214-109x(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2:e106-116. https:\/\/doi.org\/10.1016\/s2214-109x(13)70145-1","journal-title":"Lancet Glob Health"},{"key":"7275_CR3","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","volume":"127","author":"RF Spaide","year":"2020","unstructured":"Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, Waheed NK, Chakravarthy U, Rosenfeld PJ, Holz FG, Souied EH, Cohen SY, Querques G, Ohno-Matsui K, Boyer D, Gaudric A, Blodi B, Baumal CR, Li X, Coscas GJ, Brucker A, Singerman L, Luthert P, Schmitz-Valckenberg S, Schmidt-Erfurth U, Grossniklaus HE, Wilson DJ, Guymer R, Yannuzzi LA, Chew EY, Csaky K, Mon\u00e9s JM, Pauleikhoff D, Tadayoni R, Fujimoto J (2020) Consensus nomenclature for reporting neovascular age-related macular degeneration data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group. Ophthalmology 127:616\u2013636. https:\/\/doi.org\/10.1016\/j.ophtha.2019.11.004","journal-title":"Ophthalmology"},{"key":"7275_CR4","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1001\/jamaophthalmol.2020.3989","volume":"138","author":"RP Finger","year":"2020","unstructured":"Finger RP, Puth M-T, Schmid M, Barthelmes D, Guymer RH, Gillies M (2020) Lifetime outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration. JAMA Ophthalmol 138:1234\u20131240. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.3989","journal-title":"JAMA Ophthalmol"},{"key":"7275_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2415-10-31","volume":"10","author":"U Chakravarthy","year":"2010","unstructured":"Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, Buggage R, Pleil A, Mitchell P (2010) Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 10:31. https:\/\/doi.org\/10.1186\/1471-2415-10-31","journal-title":"BMC Ophthalmol"},{"key":"7275_CR6","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1136\/bjophthalmol-2016-309729","volume":"101","author":"N Joachim","year":"2017","unstructured":"Joachim N, Colijn JM, Kifley A, Lee KE, Buitendijk GHS, Klein BEK, Myers CE, Meuer SM, Tan AG, Holliday EG, Attia J, Liew G, Iyengar SK, de Jong PTVM, Hofman A, Vingerling JR, Mitchell P, Klaver CCW, Klein R, Wang JJ (2017) Five-year progression of unilateral age-related macular degeneration to bilateral involvement: the Three Continent AMD Consortium report. Br J Ophthalmol 101:1185\u20131192. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309729","journal-title":"Br J Ophthalmol"},{"key":"7275_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ajo.2010.01.007","volume":"149","author":"IA Barbazetto","year":"2010","unstructured":"Barbazetto IA, Saroj N, Shapiro H, Wong P, Ho AC, Freund KB (2010) Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR trials. Am J Ophthalmol 149:939-946.e931. https:\/\/doi.org\/10.1016\/j.ajo.2010.01.007","journal-title":"Am J Ophthalmol"},{"key":"7275_CR8","doi-asserted-by":"publisher","unstructured":"Flores R, Carneiro \u00c2, Tenreiro S, Seabra MC (2021) Retinal Progression Biomarkers of Early and Intermediate Age-Related Macular Degeneration. Life (Basel) 12 https:\/\/doi.org\/10.3390\/life12010036","DOI":"10.3390\/life12010036"},{"key":"7275_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2022.101113","volume":"92","author":"R Sacconi","year":"2023","unstructured":"Sacconi R, Fragiotta S, Sarraf D, Sadda SR, Freund KB, Parravano M, Corradetti G, Cabral D, Capuano V, Miere A, Costanzo E, Bandello F, Souied E, Querques G (2023) Towards a better understanding of non-exudative choroidal and macular neovascularization. Prog Retin Eye Res 92:101113. https:\/\/doi.org\/10.1016\/j.preteyeres.2022.101113","journal-title":"Prog Retin Eye Res"},{"key":"7275_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2019.06.017","volume":"208","author":"J Yang","year":"2019","unstructured":"Yang J, Zhang Q, Motulsky EH, Thulliez M, Shi Y, Lyu C, de Sisternes L, Durbin MK, Feuer W, Wang RK, Gregori G, Rosenfeld PJ (2019) Two-Year Risk of Exudation in Eyes with Nonexudative Age-Related Macular Degeneration and Subclinical Neovascularization Detected with Swept Source Optical Coherence Tomography Angiography. Am J Ophthalmol 208:1\u201311. https:\/\/doi.org\/10.1016\/j.ajo.2019.06.017","journal-title":"Am J Ophthalmol"},{"key":"7275_CR11","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41433-020-0936-7","volume":"35","author":"L Solecki","year":"2021","unstructured":"Solecki L, Loganadane P, Gauthier AS, Simonin M, Puyraveau M, Delbosc B, Saleh M (2021) Predictive factors for exudation of quiescent choroidal neovessels detected by OCT angiography in the fellow eyes of eyes treated for a neovascular age-related macular degeneration. Eye (Lond) 35:644\u2013650. https:\/\/doi.org\/10.1038\/s41433-020-0936-7","journal-title":"Eye (Lond)"},{"key":"7275_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ophtha.2017.08.030","volume":"125","author":"JR de Oliveira Dias","year":"2018","unstructured":"de Oliveira Dias JR, Zhang Q, Garcia JMB, Zheng F, Motulsky EH, Roisman L, Miller A, Chen C-L, Kubach S, de Sisternes L, Durbin MK, Feuer W, Wang RK, Gregori G, Rosenfeld PJ (2018) Natural history of subclinical neovascularization in nonexudative age-related macular degeneration using swept-source OCT angiography. Ophthalmology 125:255\u2013266. https:\/\/doi.org\/10.1016\/j.ophtha.2017.08.030","journal-title":"Ophthalmology"},{"key":"7275_CR13","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1097\/iae.0000000000000867","volume":"35","author":"NV Palejwala","year":"2015","unstructured":"Palejwala NV, Jia Y, Gao SS, Liu L, Flaxel CJ, Hwang TS, Lauer AK, Wilson DJ, Huang D, Bailey ST (2015) Detection of nonexudative choroidal neovascularization in age-related macular degeneration with optical coherence tomography angiography. Retina 35:2204\u20132211. https:\/\/doi.org\/10.1097\/iae.0000000000000867","journal-title":"Retina"},{"key":"7275_CR14","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1167\/iovs.16-21167","volume":"58","author":"Y Yanagi","year":"2017","unstructured":"Yanagi Y, Mohla A, Lee WK, Lee SY, Mathur R, Chan CM, Yeo I, Wong TY, Cheung CMG (2017) Prevalence and risk factors for nonexudative neovascularization in fellow eyes of patients with unilateral age-related macular degeneration and polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 58:3488\u20133495. https:\/\/doi.org\/10.1167\/iovs.16-21167","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7275_CR15","doi-asserted-by":"publisher","first-page":"e0217805","DOI":"10.1371\/journal.pone.0217805","volume":"14","author":"MJ Heiferman","year":"2019","unstructured":"Heiferman MJ, Fawzi AA (2019) Progression of subclinical choroidal neovascularization in age-related macular degeneration. PLoS ONE 14:e0217805\u2013e0217805. https:\/\/doi.org\/10.1371\/journal.pone.0217805","journal-title":"PLoS ONE"},{"key":"7275_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.oret.2019.03.008","volume":"3","author":"ST Bailey","year":"2019","unstructured":"Bailey ST, Thaware O, Wang J, Hagag AM, Zhang X, Flaxel CJ, Lauer AK, Hwang TS, Lin P, Huang D, Jia Y (2019) Detection of nonexudative choroidal neovascularization and progression to exudative choroidal neovascularization using OCT angiography. Ophthalmol Retina 3:629\u2013636. https:\/\/doi.org\/10.1016\/j.oret.2019.03.008","journal-title":"Ophthalmol Retina"},{"key":"7275_CR17","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.oret.2020.02.016","volume":"4","author":"R Laiginhas","year":"2020","unstructured":"Laiginhas R, Yang J, Rosenfeld PJ, Falc\u00e3o M (2020) Nonexudative macular neovascularization - a systematic review of prevalence, natural history, and recent insights from OCT angiography. Ophthalmol Retina 4:651\u2013661. https:\/\/doi.org\/10.1016\/j.oret.2020.02.016","journal-title":"Ophthalmol Retina"},{"key":"7275_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/tvst.9.11.6","volume":"9","author":"R Mastropasqua","year":"2020","unstructured":"Mastropasqua R, Evangelista F, Amodei F, D\u2019Aloisio R, Pinto F, Doronzo E, Viggiano P, Porreca A, Di Nicola M, Parravano M, Toto L (2020) Optical coherence tomography angiography in macular neovascularization: a comparison between different OCTA devices. Transl Vis Sci Technol 9:6\u20136. https:\/\/doi.org\/10.1167\/tvst.9.11.6","journal-title":"Transl Vis Sci Technol"},{"key":"7275_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ajo.2016.06.042","volume":"169","author":"A Carnevali","year":"2016","unstructured":"Carnevali A, Cicinelli MV, Capuano V, Corvi F, Mazzaferro A, Querques L, Scorcia V, Souied EH, Bandello F, Querques G (2016) Optical coherence tomography angiography: a useful tool for diagnosis of treatment-na\u00efve quiescent choroidal neovascularization. Am J Ophthalmol 169:189\u2013198. https:\/\/doi.org\/10.1016\/j.ajo.2016.06.042","journal-title":"Am J Ophthalmol"},{"key":"7275_CR20","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.oret.2018.02.002","volume":"2","author":"A Carnevali","year":"2018","unstructured":"Carnevali A, Sacconi R, Querques L, Marchese A, Capuano V, Rabiolo A, Corbelli E, Panozzo G, Miere A, Souied E, Bandello F, Querques G (2018) Natural history of treatment-na\u00efve quiescent choroidal neovascularization in age-related macular degeneration using OCT angiography. Ophthalmol Retina 2:922\u2013930. https:\/\/doi.org\/10.1016\/j.oret.2018.02.002","journal-title":"Ophthalmol Retina"},{"key":"7275_CR21","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/s0161-6420(03)00501-3","volume":"110","author":"R van Leeuwen","year":"2003","unstructured":"van Leeuwen R, Chakravarthy U, Vingerling JR, Brussee C, Hooghart AJ, Mulder PG, de Jong PT (2003) Grading of age-related maculopathy for epidemiological studies: is digital imaging as good as 35-mm film? Ophthalmology 110:1540\u20131544. https:\/\/doi.org\/10.1016\/s0161-6420(03)00501-3","journal-title":"Ophthalmology"},{"key":"7275_CR22","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/s0161-6420(91)32186-9","volume":"98","author":"R Klein","year":"1991","unstructured":"Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L (1991) The Wisconsin age-related maculopathy grading system. Ophthalmology 98:1128\u20131134. https:\/\/doi.org\/10.1016\/s0161-6420(91)32186-9","journal-title":"Ophthalmology"},{"key":"7275_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","volume":"125","author":"SR Sadda","year":"2018","unstructured":"Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC, Blodi BA, Bottoni F, Chakravarthy U, Chew EY, Csaky K, Danis RP, Fleckenstein M, Freund KB, Grunwald J, Hoyng CB, Jaffe GJ, Liakopoulos S, Mon\u00e9s JM, Pauleikhoff D, Rosenfeld PJ, Sarraf D, Spaide RF, Tadayoni R, Tufail A, Wolf S, Staurenghi G (2018) Consensus definition for atrophy associated with age-related macular degeneration on OCT: Classification of Atrophy Report 3. Ophthalmology 125:537\u2013548. https:\/\/doi.org\/10.1016\/j.ophtha.2017.09.028","journal-title":"Ophthalmology"},{"key":"7275_CR24","volume-title":"Epidemiology : an introduction","author":"KJ Rothman","year":"2012","unstructured":"Rothman KJ (2012) Epidemiology\u202f: an introduction. Oxford University Press, New York, NY"},{"key":"7275_CR25","volume-title":"Modern epidemiology","author":"KJ Rothman","year":"2008","unstructured":"Rothman KJ (2008) Modern epidemiology. Lippincott Williams & Wilkins, Philadelphia"},{"key":"7275_CR26","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1001\/jamaophthalmol.2021.4102","volume":"139","author":"A de Breuk","year":"2021","unstructured":"de Breuk A, Heesterbeek TJ, Bakker B, Verzijden T, Lechanteur YTE, Klaver CCW, den Hollander AI, Hoyng CB (2021) Evaluating the occurrence of rare variants in the Complement Factor H gene in patients with early-onset drusen maculopathy. JAMA Ophthalmol 139:1218\u20131226. https:\/\/doi.org\/10.1001\/jamaophthalmol.2021.4102","journal-title":"JAMA Ophthalmol"},{"key":"7275_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100952","volume":"84","author":"S de Jong","year":"2021","unstructured":"de Jong S, Gagliardi G, Garanto A, de Breuk A, Lechanteur YTE, Katti S, van den Heuvel LP, Volokhina EB, den Hollander AI (2021) Implications of genetic variation in the complement system in age-related macular degeneration. Prog Retin Eye Res 84:100952. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.100952","journal-title":"Prog Retin Eye Res"},{"key":"7275_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41377-022-00740-9","volume":"11","author":"DM Sampson","year":"2022","unstructured":"Sampson DM, Dubis AM, Chen FK, Zawadzki RJ, Sampson DD (2022) Towards standardizing retinal optical coherence tomography angiography: a review. Light Sci Appl 11:63. https:\/\/doi.org\/10.1038\/s41377-022-00740-9","journal-title":"Light Sci Appl"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07275-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07275-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07275-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:29:43Z","timestamp":1780028983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07275-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":28,"alternative-id":["7275"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07275-4","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}